Dual function of Pin1 in NR4A nuclear receptor activation: Enhanced activity of NR4As and increased Nur77 protein stability

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1823, Issue 10, 2012, Pages 1894-1904

  van Tiel, Claudia M ^a   Kurakula, Kondababu ^a   Koenis, Duco S ^a   van der Wal, Erik ^a   de Vries, Carlie J M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

NR4A nuclear receptors; Protein stability; Protein protein interaction; Transcription factor

Indexed keywords

DNA; NUCLEAR PROTEIN; NUCLEAR RECEPTOR NUR77; PEPTIDYLPROLYL ISOMERASE PIN1; PROTEIN NR4A; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; DNA BINDING; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STABILITY;

AMINO ACID SEQUENCE; CASEIN KINASE II; HEK293 CELLS; HUMANS; MEMBRANE TRANSPORT PROTEINS; MOLECULAR SEQUENCE DATA; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 1; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 2; PEPTIDYLPROLYL ISOMERASE; PROLINE; PROTEIN BINDING; PROTEIN STABILITY; PROTEIN STRUCTURE, TERTIARY; SERINE; UBIQUITINATION;

EID: 84864544409     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2012.06.030     Document Type: Article

References (56)

1. Pearen M.A., Muscat G.E. Minireview: nuclear hormone receptor 4A signaling: implications for metabolic disease. Mol. Endocrinol. 2010, 24:1891-1903.
2. van Tiel C.M., de Vries C.J. NR4All in the vessel wall. J. Steroid Biochem. Mol. Biol. 2012, 130:186-193.
3. Zhao Y., Bruemmer D. NR4A orphan nuclear receptors: transcriptional regulators of gene expression in metabolism and vascular biology. Arterioscler. Thromb. Vasc. Biol. 2010, 30:1535-1541.
4. Martinez-Gonzalez J., Badimon L. The NR4A subfamily of nuclear receptors: new early genes regulated by growth factors in vascular cells. Cardiovasc. Res. 2005, 65:609-618.
5. Maxwell M.A., Muscat G.E. The NR4A subgroup: immediate early response genes with pleiotropic physiological roles. Nucl. Recept. Signal. 2006, 4:e002.
6. Pols T.W., Bonta P.I., de Vries C.J. NR4A nuclear orphan receptors: protective in vascular disease?. Curr. Opin. Lipidol. 2007, 18:515-520.
7. Bonta P.I., van Tiel C.M., Vos M., Pols T.W., van Thienen J.V., Ferreira V., Arkenbout E.K., Seppen J., Spek C.A., van der Poll T., Pannekoek H., de Vries C.J. Nuclear receptors Nur77, Nurr1, and NOR-1 expressed in atherosclerotic lesion macrophages reduce lipid loading and inflammatory responses. Arterioscler. Thromb. Vasc. Biol. 2006, 26:2288-2294.
8. Hamers A.A., Vos M., Rassam F., van Gorp P.J., de Winther M.P., Gijbels M.J., de Waard V., de Vries C.J. Bone marrow-specific deficiency of nuclear receptor Nur77 enhances atherosclerosis. Circ. Res. 2012, 110:428-438.
9. Hanna R.N., Shaked I., Hubbeling H.G., Punt J.A., Wu R., Herrley E., Zaugg C., Pei H., Geissmann F., Ley K., Hedrick C.C. NR4A1 (Nur77) deletion polarizes macrophages toward an inflammatory phenotype and increases atherosclerosis. Circ. Res. 2012, 110:416-427.
10. Wansa K.D., Harris J.M., Muscat G.E. The activation function-1 domain of Nur77/NR4A1 mediates trans-activation, cell specificity, and coactivator recruitment. J. Biol. Chem. 2002, 277:33001-33011.
11. Philips A., Lesage S., Gingras R., Maira M.H., Gauthier Y., Hugo P., Drouin J. Novel dimeric Nur77 signaling mechanism in endocrine and lymphoid cells. Mol. Cell. Biol. 1997, 17:5946-5951.
12. Perlmann T., Jansson L. A novel pathway for vitamin A signaling mediated by RXR heterodimerization with NGFI-B and NURR1. Genes Dev. 1995, 9:769-782.
13. Flaig R., Greschik H., Peluso-Iltis C., Moras D. Structural basis for the cell-specific activities of the NGFI-B and the Nurr1 ligand-binding domain. J. Biol. Chem. 2005, 280:19250-19258.
14. Wang Z., Benoit G., Liu J., Prasad S., Aarnisalo P., Liu X., Xu H., Walker N.P., Perlmann T. Structure and function of Nurr1 identifies a class of ligand-independent nuclear receptors. Nature 2003, 423:555-560.
15. Kang S.A., Na H., Kang H.J., Kim S.H., Lee M.H., Lee M.O. Regulation of Nur77 protein turnover through acetylation and deacetylation induced by p300 and HDAC1. Biochem. Pharmacol. 2010, 80:867-873.
16. Park K.C., Song K.H., Chung H.K., Kim H., Kim D.W., Song J.H., Hwang E.S., Jung H.S., Park S.H., Bae I., Lee I.K., Choi H.S., Shong M. CR6-interacting factor 1 interacts with orphan nuclear receptor Nur77 and inhibits its transactivation. Mol. Endocrinol. 2005, 19:12-24.
17. Sohn Y.C., Kwak E., Na Y., Lee J.W., Lee S.K. Silencing mediator of retinoid and thyroid hormone receptors and activating signal cointegrator-2 as transcriptional coregulators of the orphan nuclear receptor Nur77. J. Biol. Chem. 2001, 276:43734-43739.
18. Wansa K.D., Muscat G.E. TRAP220 is modulated by the antineoplastic agent 6-Mercaptopurine, and mediates the activation of the NR4A subgroup of nuclear receptors. J. Mol. Endocrinol. 2005, 34:835-848.
19. Yeo M.G., Yoo Y.G., Choi H.S., Pak Y.K., Lee M.O. Negative cross-talk between Nur77 and small heterodimer partner and its role in apoptotic cell death of hepatoma cells. Mol. Endocrinol. 2005, 19:950-963.
20. Fischer G., Aumuller T. Regulation of peptide bond cis/trans isomerization by enzyme catalysis and its implication in physiological processes. Rev. Physiol. Biochem. Pharmacol. 2003, 148:105-150.
21. Lu K.P. Pinning down cell signaling, cancer and Alzheimer's disease. Trends Biochem. Sci. 2004, 29:200-209.
22. Ranganathan R., Lu K.P., Hunter T., Noel J.P. Structural and functional analysis of the mitotic rotamase Pin1 suggests substrate recognition is phosphorylation dependent. Cell 1997, 89:875-886.
23. Yaffe M.B., Schutkowski M., Shen M., Zhou X.Z., Stukenberg P.T., Rahfeld J.U., Xu J., Kuang J., Kirschner M.W., Fischer G., Cantley L.C., Lu K.P. Sequence-specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism. Science 1997, 278:1957-1960.
24. Lu K.P., Liou Y.C., Zhou X.Z. Pinning down proline-directed phosphorylation signaling. Trends Cell Biol. 2002, 12:164-172.
25. Lu K.P., Zhou X.Z. The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease. Nat. Rev. Mol. Cell Biol. 2007, 8:904-916.
26. Ryo A., Liou Y.C., Lu K.P., Wulf G. Prolyl isomerase Pin1: a catalyst for oncogenesis and a potential therapeutic target in cancer. J. Cell Sci. 2003, 116:773-783.
27. Lu K.P., Hanes S.D., Hunter T. A human peptidyl-prolyl isomerase essential for regulation of mitosis. Nature 1996, 380:544-547.
28. Winkler K.E., Swenson K.I., Kornbluth S., Means A.R. Requirement of the prolyl isomerase Pin1 for the replication checkpoint. Science 2000, 287:1644-1647.
29. Wulf G.M., Liou Y.C., Ryo A., Lee S.W., Lu K.P. Role of Pin1 in the regulation of p53 stability and p21 transactivation, and cell cycle checkpoints in response to DNA damage. J. Biol. Chem. 2002, 277:47976-47979.
30. Wu X., Wilcox C.B., Devasahayam G., Hackett R.L., Arevalo-Rodriguez M., Cardenas M.E., Heitman J., Hanes S.D. The Ess1 prolyl isomerase is linked to chromatin remodeling complexes and the general transcription machinery. EMBO J. 2000, 19:3727-3738.
31. Xu Y.X., Manley J.L. Pin1 modulates RNA polymerase II activity during the transcription cycle. Genes Dev. 2007, 21:2950-2962.
32. Fujimoto Y., Shiraki T., Horiuchi Y., Waku T., Shigenaga A., Otaka A., Ikura T., Igarashi K., Aimoto S., Tate S., Morikawa K. Proline cis/trans-isomerase Pin1 regulates peroxisome proliferator-activated receptor gamma activity through the direct binding to the activation function-1 domain. J. Biol. Chem. 2010, 285:3126-3132.
33. Shaw P.E. Peptidyl-prolyl cis/trans isomerases and transcription: is there a twist in the tail?. EMBO Rep. 2007, 8:40-45.
34. Chen H.Z., Li L., Wang W.J., Du X.D., Wen Q., He J.P., Zhao B.X., Li G.D., Zhou W., Xia Y., Yang Q.Y., Hew C.L., Liou Y.C., Wu Q. Prolyl isomerase Pin1 stabilizes and activates orphan nuclear receptor TR3 to promote mitogenesis. Oncogene 2012, 31:2876-2887.
35. Kurakula K., van der Wal E., Geerts D., van Tiel C.M., de Vries C.J. FHL2 is a novel corepressor of nuclear receptor Nur77. J. Biol. Chem. 2011, 286:44336-44343.
36. Barry S.C., Harder B., Brzezinski M., Flint L.Y., Seppen J., Osborne W.R. Lentivirus vectors encoding both central polypurine tract and posttranscriptional regulatory element provide enhanced transduction and transgene expression. Hum. Gene Ther. 2001, 12:1103-1108.
37. Turowec J.P., Duncan J.S., French A.C., Gyenis L., St Denis N.A., Vilk G., Litchfield D.W. Protein kinase CK2 is a constitutively active enzyme that promotes cell survival: strategies to identify CK2 substrates and manipulate its activity in mammalian cells. Methods Enzymol. 2010, 484:471-493.
38. Maira M., Martens C., Philips A., Drouin J. Heterodimerization between members of the Nur subfamily of orphan nuclear receptors as a novel mechanism for gene activation. Mol. Cell. Biol. 1999, 19:7549-7557.
39. Root D.E., Hacohen N., Hahn W.C., Lander E.S., Sabatini D.M. Genome-scale loss-of-function screening with a lentiviral RNAi library. Nat. Methods 2006, 3:715-719.
40. de Vries C.J., van Achterberg T.A., Horrevoets A.J., ten Cate J.W., Pannekoek H. Differential display identification of 40 genes with altered expression in activated human smooth muscle cells. Local expression in atherosclerotic lesions of smags, smooth muscle activation-specific genes. J. Biol. Chem. 2000, 275:23939-23947.
41. Yuan B., Latek R., Hossbach M., Tuschl T., Lewitter F. siRNA selection server: an automated siRNA oligonucleotide prediction server. Nucleic Acids Res. 2004, 32:W130-W134.
42. Nomiyama T., Nakamachi T., Gizard F., Heywood E.B., Jones K.L., Ohkura N., Kawamori R., Conneely O.M., Bruemmer D. The NR4A orphan nuclear receptor NOR1 is induced by platelet-derived growth factor and mediates vascular smooth muscle cell proliferation. J. Biol. Chem. 2006, 281:33467-33476.
43. Pei L., Waki H., Vaitheesvaran B., Wilpitz D.C., Kurland I.J., Tontonoz P. NR4A orphan nuclear receptors are transcriptional regulators of hepatic glucose metabolism. Nat. Med. 2006, 12:1048-1055.
44. Lu P.J., Zhou X.Z., Shen M., Lu K.P. Function of WW domains as phosphoserine- or phosphothreonine-binding modules. Science 1999, 283:1325-1328.
45. Zhou X.Z., Kops O., Werner A., Lu P.J., Shen M., Stoller G., Kullertz G., Stark M., Fischer G., Lu K.P. Pin1-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins. Mol. Cell 2000, 6:873-883.
46. Lu P.J., Wulf G., Zhou X.Z., Davies P., Lu K.P. The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein. Nature 1999, 399:784-788.
47. Chintharlapalli S., Burghardt R., Papineni S., Ramaiah S., Yoon K., Safe S. Activation of Nur77 by selected 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes induces apoptosis through nuclear pathways. J. Biol. Chem. 2005, 280:24903-24914.
48. Wansa K.D., Harris J.M., Yan G., Ordentlich P., Muscat G.E. The AF-1 domain of the orphan nuclear receptor NOR-1 mediates trans-activation, coactivator recruitment, and activation by the purine anti-metabolite 6-mercaptopurine. J. Biol. Chem. 2003, 278:24776-24790.
49. Pires N.M., Pols T.W., de Vries M.R., van Tiel C.M., Bonta P.I., Vos M., Arkenbout E.K., Pannekoek H., Jukema J.W., Quax P.H., de Vries C.J. Activation of nuclear receptor Nur77 by 6-mercaptopurine protects against neointima formation. Circulation 2007, 115:493-500.
50. Lufei C., Koh T.H., Uchida T., Cao X. Pin1 is required for the Ser727 phosphorylation-dependent Stat3 activity. Oncogene 2007, 26:7656-7664.
51. Woronicz J.D., Lina A., Calnan B.J., Szychowski S., Cheng L., Winoto A. Regulation of the Nur77 orphan steroid receptor in activation-induced apoptosis. Mol. Cell. Biol. 1995, 15:6364-6376.
52. Pekarsky Y., Hallas C., Palamarchuk A., Koval A., Bullrich F., Hirata Y., Bichi R., Letofsky J., Croce C.M. Akt phosphorylates and regulates the orphan nuclear receptor Nur77. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:3690-3694.
53. Wingate A.D., Campbell D.G., Peggie M., Arthur J.S. Nur77 is phosphorylated in cells by RSK in response to mitogenic stimulation. Biochem. J. 2006, 393:715-724.
54. Katagiri Y., Takeda K., Yu Z.X., Ferrans V.J., Ozato K., Guroff G. Modulation of retinoid signalling through NGF-induced nuclear export of NGFI-B. Nat. Cell Biol. 2000, 2:435-440.
55. Kolluri S.K., Bruey-Sedano N., Cao X., Lin B., Lin F., Han Y.H., Dawson M.I., Zhang X.K. Mitogenic effect of orphan receptor TR3 and its regulation by MEKK1 in lung cancer cells. Mol. Cell. Biol. 2003, 23:8651-8667.
56. Garat C.V., Crossno J.T., Sullivan T.M., Reusch J.E., Klemm D.J. Thiazolidinediones prevent PDGF-BB-induced CREB depletion in pulmonary artery smooth muscle cells by preventing upregulation of casein kinase 2 alpha' catalytic subunit. J. Cardiovasc. Pharmacol. 2010, 55:469-480.